Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multiple Ascending Dose Phase I Study of the M1 Positive Allosteric Modulator VU0467319

NCT04051801 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.

NCT NCT04051801
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04051801 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multiple Ascending Dose Phase I Study of the M1 Positive Allosteric Modulator VU0467319
Lead sponsor
Vanderbilt University Medical Center
Phase
Phase 1
Overall status
Withdrawn
Start date
May 25, 2021
Completion date
May 25, 2021
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive impairment